Literature DB >> 6214398

Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate.

A C Perkins, J G Hardy, M L Wastie, K M Clifford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214398     DOI: 10.1007/bf00253429

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


× No keyword cloud information.
  9 in total

1.  Significance of absent or faint kidney sign on bone scan.

Authors:  W M Sy; D Patel; H Faunce
Journal:  J Nucl Med       Date:  1975-06       Impact factor: 10.057

2.  Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton.

Authors:  I Fogelman; J H McKillop; I T Boyle; W R Greig
Journal:  Eur J Nucl Med       Date:  1977-12-30

Review 3.  Carcinoma of the prostate: a review.

Authors:  W J Catalona; W W Scott
Journal:  J Urol       Date:  1978-01       Impact factor: 7.450

4.  An index for monitoring bone metastases from carcinoma of the prostate.

Authors:  J G Hardy; A E Kulatilake; M L Wastie
Journal:  Br J Radiol       Date:  1980-09       Impact factor: 3.039

5.  Recognition of the superscan in prostatic bone scintigraphy.

Authors:  A R Constable; R W Cranage
Journal:  Br J Radiol       Date:  1981-02       Impact factor: 3.039

6.  Accuracy of 99mTC-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases.

Authors:  J D Osmond; H P Pendergrass; M S Potsaid
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-12

7.  Radioisotopic bone scintigraphy with the gamma camera in the investigation of prostatic cancer.

Authors:  R J Shearer; A R Constable; M Girling; W F Hendry; J D Fergusson
Journal:  Br Med J       Date:  1974-05-18

8.  Altered androgen metabolism in metastatic prostate cancer.

Authors:  B Kliman; G R Prout; R A Maclaughlin; J J Daly; P P Griffin
Journal:  J Urol       Date:  1978-05       Impact factor: 7.450

9.  Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.

Authors:  H Langhammer; R Sintermann; G Hör; H W Pabst
Journal:  Nuklearmedizin       Date:  1978-07       Impact factor: 1.379

  9 in total
  1 in total

1.  Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy.

Authors:  G M Sundkvist; L Ahlgren; B Lilja; S Mattsson; P A Abrahamsson; L B Wadström
Journal:  Eur J Nucl Med       Date:  1988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.